Regulation of cancer cell survival by Par-4

Padhma Ranganathan1, Vivek M Rangnekar

  • 1Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536, USA.

Insights

Prostate apoptosis response-4 (Par-4) protein selectively triggers cancer cell death and enhances apoptosis. Its regulatory mechanisms offer potential for developing targeted cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Prostate apoptosis response-4 (Par-4) is a pro-apoptotic protein.
  • Par-4 exhibits selective toxicity towards cancer cells.
  • It sensitizes cells to apoptotic stimuli and promotes tumor regression.

Purpose of the Study:

  • To review the structural and functional characteristics of Par-4.
  • To explore the regulatory mechanisms governing Par-4's apoptotic function.
  • To highlight the therapeutic potential of Par-4 in cancer treatment.

Main Methods:

  • Literature review of existing research on Par-4.
  • Analysis of structural and functional data.
  • Discussion of regulatory pathways and therapeutic applications.

Main Results:

  • Par-4 possesses unique properties for inducing cancer cell apoptosis.
  • Its function is regulated at multiple levels.
  • Par-4 can be leveraged for targeted cancer therapy.

Conclusions:

  • Par-4 is a promising target for cancer therapy due to its selective pro-apoptotic activity.
  • Understanding Par-4's regulation is key to developing effective cancer treatments.
  • Further research into Par-4's mechanisms can lead to novel therapeutic strategies.

Related Concept Videos

Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...